1994
DOI: 10.1161/01.atv.14.1.115
|View full text |Cite
|
Sign up to set email alerts
|

Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL.

Abstract: The topographic distribution of atherosclerotic lesions is influenced by biochemical factors intrinsic to the arterial wall. In the present work we have investigated whether the composition/chemical structure of glycosaminoglycans constitutes one of these factors. Normal human arteries were obtained at necropsy, and in order of decreasing susceptibility to atherosclerosis, consisted of the abdominal and thoracic aortas and the iliac and pulmonary arteries. The results showed similar concentrations of total gly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
66
0
1

Year Published

1998
1998
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 97 publications
(68 citation statements)
references
References 49 publications
1
66
0
1
Order By: Relevance
“…35 7-KC and lysoPC regulate chain elongation on all of the major secreted proteoglycan species. This may be functionally significant, because longer chains are correlated with increased LDL binding, 25,31 and these compounds did indeed stimulate synthesis of proteoglycans with enhanced lipoprotein-binding properties. The ability of both compounds to cause chain elongation suggests nonspecific regulation, perhaps attributable to increases in the amount/activity of the enzymes responsible for chain synthesis.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…35 7-KC and lysoPC regulate chain elongation on all of the major secreted proteoglycan species. This may be functionally significant, because longer chains are correlated with increased LDL binding, 25,31 and these compounds did indeed stimulate synthesis of proteoglycans with enhanced lipoprotein-binding properties. The ability of both compounds to cause chain elongation suggests nonspecific regulation, perhaps attributable to increases in the amount/activity of the enzymes responsible for chain synthesis.…”
Section: Discussionmentioning
confidence: 94%
“…25,31 Therefore, the LDL-binding properties of proteoglycans synthesized in the presence of lysoPC were evaluated (Figure 4). Because of the finding that the ratio of small proteoglycans is altered by lysoPC, we chose to focus on peak 2 in this assay.…”
Section: -Kc and Lysopc Cause Chain Elongation That Is Correlated Wimentioning
confidence: 99%
“…Heparan sulfate from human aorta was extracted and purified as described previously (18 (Rockville, MD). Agarose (standard low M r ) was obtained from Bio-Rad; toluidine blue and alcian blue were from Fisher; human antithrombin, human factor Xa, and thrombin were from Hematologic Technologies Inc.; thrombin chromogenic substrate tosyl-Gly-Pro-Arg-p-nitroanilide acetate (Chromozyn TH) and factor Xa chromogenic substrate N-methoxycarbonyl-D-norleucyl-glycyl-L-arginine-4-nitranillide-acetate were from Amersham Biosciences.…”
Section: Methodsmentioning
confidence: 99%
“…It is known that certain glycosaminoglycan species, including particular populations of a given species, have greater affinity for LDL. 6,11,16 The occurrence of atherosclerotic lesions is associated with a number of risk factors, such as elevated serum lipoprotein levels, hypertension, smoking, gender, and family history. 17 However, intrinsic factors of the arterial bed and its bloodcarrying functions also influence the occurrence of lesions.…”
mentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8][9][10][11] This is a step in the normal exchange of components between the circulating plasma and the arterial wall. However, during atherosclerosis, this process contributes to continuous focal deposition of cholesterol-rich lipoproteins, mainly LDL, in lesions.…”
mentioning
confidence: 99%